More Data Assuage Suicide Concerns With GLP-1 Agents

[ad_1]

(MedPage Today) — Risk of suicidality wasn’t higher for type 2 diabetes patients starting on GLP-1 receptor agonists than for those on two other popular classes of diabetes drugs, a U.K. cohort study found.
In fully adjusted models, new initiators…

[ad_2]

Source link : https://www.medpagetoday.com/endocrinology/diabetes/114394

Author :

Publish date : 2025-02-26 23:30:00

Copyright for syndicated content belongs to the linked Source.